Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Last updated: 2020
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2020
- December 202010 results available
- November 20208 results available
- October 202018 results available
- September 202013 results available
- August 20208 results available
- July 202014 results available
- June 202011 results available
- May 202015 results available
- April 202016 results available
- March 202014 results available
- February 20209 results available
- January 202010 results available
Recall class
Displaying 46 - 60 of 146 items.
Unauthorized products may pose serious health risks (September 16, 2020: Part 2)
AlertPublic advisory | 2020-09-16
Importation of US Clinical Trial-Labelled Remdesivir for Injection Due to Shortage of Canadian-Labelled Remdesivir
AlertHealth professional risk communication | 2020-09-15
ESBRIET (pirfenidone) and the Risk of Drug-Induced Liver Injury
AlertHealth professional risk communication | 2020-09-14
Jardiance (2020-09-14)
RecallHealth product recall | 2020-09-14
Dexedrine Spansule SRC 10MG (2020-08-28)
RecallHealth product recall | 2020-08-28
pms-Ranitidine 150mg (2020-08-28)
RecallHealth product recall | 2020-08-28
Ranitidine Injection USP (2020-08-27)
RecallHealth product recall | 2020-08-27
Prescription Cough and Cold Products Containing Opioids and the Risk of Opioid Use Disorder in Children and Adolescents (< 18 years of age)
AlertHealth professional risk communication | 2020-08-24
Teva Canada Limited Product Recall (2020-08-21)
RecallHealth product recall | 2020-08-21
Acyclovir Sodium Injection (2020-08-18)
RecallHealth product recall | 2020-08-18
Mirage Antibacterial Wipes (2020-08-08)
RecallHealth product recall | 2020-08-08
Extra Strength Diaper Rash Ointment (2020-08-03)
RecallHealth product recall | 2020-08-03
Non-prescription pain relief products containing codeine are not recommended for use in people under 18 years of age
AlertPublic advisory | 2020-07-31
Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms
AlertPublic advisory | 2020-07-28
Teva-Triamterene/HCTZ (2020-07-24)
RecallHealth product recall | 2020-07-24